A history of the pharmacological treatment of bipolar disorder

Francisco López-Muñoz, Winston W. Shen, Pilar D’ocon, Alejandro Romero, Cecilio Álamo

研究成果: 雜誌貢獻回顧型文獻同行評審

41 引文 斯高帕斯(Scopus)

摘要

In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade’s experiments with lithium and the beginning of the so-called “Psychopharmacological Revolution” in the 1950s. We also describe the clinical studies and development processes, enabling the therapeutic introduction of pharmacological agents currently available for the treatment of bipolar disorder in its different phases and manifestations. Those drugs include lithium salts, valproic acid, carbamazepine, new antiepileptic drugs, basically lamotrigine and atypical antipsychotic agents (olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, asenapine, cariprazine and lurasidone). Finally, the socio-sanitary implications derived from the clinical introduction of these drugs are also discussed.

原文英語
文章編號2143
期刊International journal of molecular sciences
19
發行號7
DOIs
出版狀態已發佈 - 七月 23 2018

ASJC Scopus subject areas

  • 催化
  • 分子生物學
  • 光譜
  • 電腦科學應用
  • 物理與理論化學
  • 有機化學
  • 無機化學

指紋

深入研究「A history of the pharmacological treatment of bipolar disorder」主題。共同形成了獨特的指紋。

引用此